7-150996504-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_000603.5(NOS3):āc.371T>Gā(p.Leu124Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 1,606,142 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000054 ( 0 hom., cov: 27)
Exomes š: 0.0000089 ( 0 hom. )
Consequence
NOS3
NM_000603.5 missense
NM_000603.5 missense
Scores
8
11
Clinical Significance
Conservation
PhyloP100: 3.32
Genes affected
NOS3 (HGNC:7876): (nitric oxide synthase 3) Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 8 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NOS3 | NM_000603.5 | c.371T>G | p.Leu124Arg | missense_variant | 4/27 | ENST00000297494.8 | |
NOS3 | NM_001160111.1 | c.371T>G | p.Leu124Arg | missense_variant | 3/14 | ||
NOS3 | NM_001160110.1 | c.371T>G | p.Leu124Arg | missense_variant | 3/14 | ||
NOS3 | NM_001160109.2 | c.371T>G | p.Leu124Arg | missense_variant | 3/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NOS3 | ENST00000297494.8 | c.371T>G | p.Leu124Arg | missense_variant | 4/27 | 1 | NM_000603.5 | P1 | |
NOS3 | ENST00000484524.5 | c.371T>G | p.Leu124Arg | missense_variant | 3/14 | 1 | |||
NOS3 | ENST00000467517.1 | c.371T>G | p.Leu124Arg | missense_variant | 3/14 | 1 | |||
NOS3 | ENST00000461406.5 | c.-37+1190T>G | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000542 AC: 8AN: 147610Hom.: 0 Cov.: 27
GnomAD3 genomes
AF:
AC:
8
AN:
147610
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000413 AC: 1AN: 242398Hom.: 0 AF XY: 0.00000756 AC XY: 1AN XY: 132258
GnomAD3 exomes
AF:
AC:
1
AN:
242398
Hom.:
AF XY:
AC XY:
1
AN XY:
132258
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000891 AC: 13AN: 1458532Hom.: 0 Cov.: 34 AF XY: 0.00000965 AC XY: 7AN XY: 725382
GnomAD4 exome
AF:
AC:
13
AN:
1458532
Hom.:
Cov.:
34
AF XY:
AC XY:
7
AN XY:
725382
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000542 AC: 8AN: 147610Hom.: 0 Cov.: 27 AF XY: 0.0000557 AC XY: 4AN XY: 71776
GnomAD4 genome
AF:
AC:
8
AN:
147610
Hom.:
Cov.:
27
AF XY:
AC XY:
4
AN XY:
71776
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2022 | The c.371T>G (p.L124R) alteration is located in exon 4 (coding exon 3) of the NOS3 gene. This alteration results from a T to G substitution at nucleotide position 371, causing the leucine (L) at amino acid position 124 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Benign
D;D;D
Sift4G
Benign
T;T;T
Polyphen
P;.;.
Vest4
MutPred
Gain of MoRF binding (P = 0.0189);Gain of MoRF binding (P = 0.0189);Gain of MoRF binding (P = 0.0189);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at